PO.TB04.07 · 肿瘤生物学

使用Harbor-IN系统对基于转座子的基因插入进行基于DoE的优化

DoE-based optimization of transposon-based gene insertion using the Harbor-IN system

海报缩略图:使用Harbor-IN系统对基于转座子的基因插入进行基于DoE的优化
编号 3420 展板 25 时间 4/20 02:00–05:00 区域 Section 28 主讲 Julia Schueler, DVM;PhD
分会场 In Vitro Models 1: 2D and 3D
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Kanstantsin Lashuk1, Corey Brizzee2, Ina Rohleff1, Julia B. Schueler1

1Charles River Laboratories, Freiburg, Germany,2Demeetra, Lexington, KY

摘要 Abstract

中文摘要
高效且安全的哺乳动物细胞遗传标记对于细胞追踪、功能测定和高通量筛选等应用至关重要。在本研究中,我们开发并优化了一种生物安全1级(BSL-1)方案,用于使用基于转座子的系统稳定整合荧光和发光报告基因。采用实验设计(DoE)方法系统性地优化编码报告基因的质粒DNA与编码转座酶的体外转录RNA的共转染条件。评估了四种常用转染试剂——Lipofectamine 3000、PEI、ViaFect和jetPRIME——的效率及其与该系统的兼容性。改变核酸比例、总载量和试剂浓度等关键因素,以在维持细胞活力的同时最大化整合效率。优化后的方案在多种细胞类型中实现了稳健且可重现的报告基因表达,无需病毒载体或更高的生物安全防护。这项工作提供了一种可扩展的非病毒策略,用于在标准实验室条件下生成稳定标记的细胞群,实现成像、功能基因组学和测定开发等下游应用。
查看英文原文 English abstract
Efficient and safe genetic labeling of mammalian cells is essential for applications in cell tracking, functional assays, and high-throughput screening. In this study, we developed and optimized a biosafety level 1 (BSL-1) protocol for stable integration of fluorescent and luminescent reporter genes using a transposon-based system. A Design of Experiments (DoE) approach was employed to systematically optimize co-transfection conditions of plasmid DNA encoding the reporter gene and in vitro-transcribed RNA encoding the transposase. Four commonly used transfection reagents-Lipofectamine 3000, PEI, ViaFect, and jetPRIME-were evaluated for their efficiency and compatibility with the system. Key factors such as nucleic acid ratios, total cargo amount, and reagent concentration were varied to maximize integration efficiency while maintaining cell viability. The optimized protocol achieved robust and reproducible reporter expression across multiple cell types without requiring viral vectors or higher biosafety containment. This work provides a scalable, non-viral strategy for generating stably labeled cell populations, enabling downstream applications in imaging, functional genomics, and assay development under standard laboratory conditions.
利益披露 Disclosure
K. Lashuk, None.. C. Brizzee, None.. I. Rohleff, None.. J. B. Schueler, None.

← 返回 AACR 2026 检索